Clinical Trial Update: Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial assessing the safety and efficacy of a topical gel combining clindamycin phosphate 1.2% and tretinoin 0.025% for rosacea; the study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• Clindamycin Phosphate 1.2% (clindamycin phosphate)
• Tretinoin 0.025% (tretinoin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Rosacea | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-06-15